JK

Jeffrey Kadanoff

Senior finance and corporate development leader

Greater Montreal Metropolitan Area

Invests in

  • Min Investment:

    $500,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $3,000,000.00

Education

Work Experience

2024

  • Chief Financial Officer

    2024

2019 - 2024

  • Managing Director

    2019 - 2024

    Esplanade Ventures is an early-stage digital health venture fund.

  • Interim Chief Financial Officer

    2020 - 2022

2018 - 2019

  • Chief Financial Officer / Consultant

    2018 - 2019

2017 - 2018

  • Chief Financial Officer

    2017 - 2018

  • Chief Financial Officer

    2014 - 2017

    Knight Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets.

  • Strategy Consulltant

    2013 - 2014

    Advise on strategic planning, market feasibility and growth strategy for clients such as Cirque du Soleil, Edipresse and Paladin Labs.

2011 - 2013

  • Vice President - Strategic Planning and Development

    2011 - 2013

    Reporting to the COO, manage a group of 25 employees, as head of strategy for specialty apparel retailer with over $1B in sales. Responsibilities include strategic planning, mergers & acquisitions, corporate development, ecommerce development, customer insights and strategic partnerships.

1997 - 2011

  • Principal

    1997 - 2011

    Collaborate as a trusted advisor with clients’ VPs and C-level executives to drive strategic change and operational improvements. Responsible for strategy, project management, senior client relationships and team management.

1994 - 1997

  • Process Engineer

    1994 - 1997

    Develop several large scale chemical processing plants. Perform key engineering duties ranging from capital and operating cost estimates, equipment design and selection, and plant start-up procedures.